logo

For the Inventor, By the Inventor

Trondheim, Norway

Avexxin as


USPTO Granted Patents = 22

% Expired Patents = 54.5



Forward Citations = 54

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Berit Johansen (19 out of 19 patents)

silverMedal Inger-Reidun Aukrust (7 out of 7 patents)

bronzeMedal George Kokotos (7 out of 11 patents)

4.  Marcel Sanderberg (4 out of 4 patents)

5.  Marit Anthonsen (4 out of 4 patents)

6.  Wenche Sjursen (4 out of 4 patents)

7.  Lars Skattebol (4 out of 7 patents)

8.  Anne Kristen Holmeide (4 out of 4 patents)

9.  Marcel Sandberg (3 out of 7 patents)

10.  Efrosini Barbayianni (3 out of 4 patents)

11.  Thomas Brimert (2 out of 10 patents)

12.  Astrid Jullumstrø Feuerherm (2 out of 2 patents)

13.  Johan Evenäs (2 out of 4 patents)

14.  Kildahl-Andersen Geir (2 out of 2 patents)

15.  Victoria Magrioti (2 out of 3 patents)


22 patents:

1. 11691959 - Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds (2023-07-04),
2. 11439625 - Combination therapy for proliferative diseases (2022-09-13),
3. 11351127 - Pharmaceutical composition (2022-06-07),
4. 11034666 - Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds (2021-06-15),
5. 10953004 - Combination therapy for proliferative diseases (2021-03-23),
6. 10851114 - 2-oxothiatole compounds having activity as cPLAinhibitors for the treatment of inflammatory disorders and hyperproliferative disorders (2020-12-01),
7. 10758499 - Dermatitis treatment (2020-09-01),
8. 10370344 - 2-oxothiazole compounds and method of using same for chronic inflammatory disorders (2019-08-06),
9. 10259801 - Anti-inflammatory and antitumor 2-oxothiazoles ABD 2-oxothiophenes compounds (2019-04-16),
10. 10183911 - Process for the preparation of a polyunsaturated ketone compound (2019-01-22),
11. 10150781 - 2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders (2018-12-11),
12. 10093618 - Process for the preparation of a polyunsaturated ketone compound (2018-10-09),
13. 10085953 - Skin cancer treatment (2018-10-02),
14. 10085952 - Dermatitis treatment (2018-10-02),
15. 9682930 - Rheumatoid arthritis treatment (2017-06-20),
Company Overview
Avexxin AS is a biotechnology company based in Trondheim, Norway, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing advanced biopharmaceutical technologies to address unmet medical needs, particularly in the fields of immunology and oncology. Through its research initiatives, Avexxin aims to create effective treatments that enhance patient outcomes and contribute to the advancement of healthcare. The company is dedicated to fostering scientific collaboration and innovation within the biopharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Avexxin as USPTO Patent Assignee Logo
22 Patents

#7 in Trondheim

#74 in Norway

#28,782 in the World

Trondheim, NO
Trondheim, Norway

Avexxin as

Forward Citations = 54

21 inventors:

goldMedal Berit Johansen (19 out of 19 patents)

silverMedal Inger-Reidun Aukrust (7 out of 7 patents)

bronzeMedal George Kokotos (7 out of 11 patents)

4.  Marcel Sanderberg (4 out of 4 patents)

5.  Marit Anthonsen (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Avexxin as. Retrieved from https://idiyas.com/company/avexxin-as

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…